220 related articles for article (PubMed ID: 29081003)
1. Phylogenetically Conserved Sequences Around Myelin P0 Stop Codon are Essential for Translational Readthrough to Produce L-MPZ.
Yamaguchi Y; Baba H
Neurochem Res; 2018 Jan; 43(1):227-237. PubMed ID: 29081003
[TBL] [Abstract][Full Text] [Related]
2. L-MPZ, a novel isoform of myelin P0, is produced by stop codon readthrough.
Yamaguchi Y; Hayashi A; Campagnoni CW; Kimura A; Inuzuka T; Baba H
J Biol Chem; 2012 May; 287(21):17765-17776. PubMed ID: 22457349
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of large myelin protein zero leads to Charcot-Marie-Tooth disease-like neuropathy in mice.
Otani Y; Ohno N; Cui J; Yamaguchi Y; Baba H
Commun Biol; 2020 Mar; 3(1):121. PubMed ID: 32170207
[TBL] [Abstract][Full Text] [Related]
4. Influence of novel readthrough agents on myelin protein zero translation in the peripheral nervous system.
Otani Y; Taguchi A; Hamada K; Hayashi Y; Yamaguchi Y; Baba H
Neuropharmacology; 2022 Jun; 211():109059. PubMed ID: 35417746
[TBL] [Abstract][Full Text] [Related]
5. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
6. Complete Loss of Myelin protein zero (MPZ) in a patient with a late onset Charcot-Marie-Tooth (CMT).
Gharesouran J; Hosseinzadeh H; Naghiloo A; Ghafouri-Fard S; Hussen BM; Taheri M; Rezazadeh M; Samadian M
Metab Brain Dis; 2023 Aug; 38(6):1963-1970. PubMed ID: 36952089
[TBL] [Abstract][Full Text] [Related]
7. Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth disease.
Roa BB; Warner LE; Garcia CA; Russo D; Lovelace R; Chance PF; Lupski JR
Hum Mutat; 1996; 7(1):36-45. PubMed ID: 8664899
[TBL] [Abstract][Full Text] [Related]
8. A novel mutation of myelin protein zero associated with an axonal form of Charcot-Marie-Tooth disease.
Santoro L; Manganelli F; Di Maria E; Bordo D; Cassandrini D; Ajmar F; Mandich P; Bellone E
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):262-5. PubMed ID: 14742601
[TBL] [Abstract][Full Text] [Related]
9. Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene: short report.
Kochański A; Drac H; Jedrzejowska H; Hausmanowa-Petrusewicz I
Eur J Neurol; 2003 Sep; 10(5):547-9. PubMed ID: 12940837
[TBL] [Abstract][Full Text] [Related]
10. Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients.
Su Y; Brooks DG; Li L; Lepercq J; Trofatter JA; Ravetch JV; Lebo RV
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10856-60. PubMed ID: 7504284
[TBL] [Abstract][Full Text] [Related]
11. A nonsense mutation in myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function.
Fratta P; Ornaghi F; Dati G; Zambroni D; Saveri P; Belin S; D'Adamo P; Shy M; Quattrini A; Laura Feltri M; Wrabetz L
Hum Mol Genet; 2019 Jan; 28(1):124-132. PubMed ID: 30239779
[TBL] [Abstract][Full Text] [Related]
12. A novel MPZ mutation in Charcot-Marie-Tooth disease type 1B with focally folded myelin and multiple entrapment neuropathies.
Iida M; Koike H; Ando T; Sugiura M; Yamamoto M; Tanaka F; Sobue G
Neuromuscul Disord; 2012 Feb; 22(2):166-9. PubMed ID: 21940171
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation, Thr65Ala, in the MPZ gene in a patient with Charcot-Marie-Tooth type 1B disease with focally folded myelin.
Kochanski A; Drac H; Kabzińska D; Hausmanowa-Petrusewicz I
Neuromuscul Disord; 2004 Mar; 14(3):229-32. PubMed ID: 15036333
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic description of a family with Charcot-Marie-Tooth disease type 1B from a transmembrane MPZ mutation.
Eggers SD; Keswani SC; Melli G; Cornblath DR
Muscle Nerve; 2004 Jun; 29(6):867-9. PubMed ID: 15170620
[TBL] [Abstract][Full Text] [Related]
15. Major myelin protein gene (P0) mutation causes a novel form of axonal degeneration.
Li J; Bai Y; Ianakova E; Grandis M; Uchwat F; Trostinskaia A; Krajewski KM; Garbern J; Kupsky WJ; Shy ME
J Comp Neurol; 2006 Sep; 498(2):252-65. PubMed ID: 16856127
[TBL] [Abstract][Full Text] [Related]
16. Charcot-Marie-Tooth 1B caused by expansion of a familial myelin protein zero (MPZ) gene duplication.
Speevak MD; Farrell SA
Eur J Med Genet; 2013 Oct; 56(10):566-9. PubMed ID: 23811036
[TBL] [Abstract][Full Text] [Related]
17. Altered trafficking and adhesion function of MPZ mutations and phenotypes of Charcot-Marie-Tooth disease 1B.
Matsuyama W; Nakagawa M; Takashima H; Osame M
Acta Neuropathol; 2002 May; 103(5):501-8. PubMed ID: 11935267
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
19. Charcot-Marie-Tooth disease and related peripheral neuropathies: novel mutations in the peripheral myelin genes connexin 32 (Cx32), peripheral myelin protein 22 (PMP22), and peripheral myelin protein zero (MPZ).
Ekici AB; Schweitzer D; Park O; Lorek D; Rautenstrauss B; Krüger G; Friedl W; Uhlhaas S; Bathke K; Heuss D; Kayser C; Grehl H
Neurogenetics; 2000 Sep; 3(1):49-50. PubMed ID: 11085599
[No Abstract] [Full Text] [Related]
20. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.
Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G;
Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
